Condition
Cognitive Abnormality
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting2
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07812337Not ApplicableNot Yet RecruitingPrimary
Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
NCT05201534Not ApplicableRecruiting
Interventions in Mathematics and Cognitive Skills
NCT07588685Not Yet Recruiting
Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Cognitive Impairment
NCT07222280Not ApplicableRecruiting
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
NCT03246269Completed
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
Showing all 5 trials